Langworthy proposes bipartisan legislation to speed biosimilar drug market access and lower prescription costs.
Quiver AI Summary
Langworthy introduces biosimilars bill: Congressman Nick Langworthy announced the Biosimilars Access and Affordability Act, a bipartisan measure aimed at expanding access to lower-cost biosimilar prescription drugs. Senator Marsha Blackburn is leading the companion bill in the Senate.
What the proposal would do: The bill would update Medicare policy to create a clearer process for delaying price negotiations when a biosimilar is expected to reach the market, while setting a two-year limit and adding safeguards if the competing drug does not materialize.
Supporters and backers: The release says several lawmakers from both parties are co-leading or backing the bill, along with patient and disease advocacy groups. Supporters said the measure could increase competition, lower drug costs, and give patients more treatment options.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
Nicholas A. Langworthy Fundraising
Nicholas A. Langworthy recently disclosed $314.1K of fundraising in a Q2 FEC disclosure filed on July 11th, 2026. This was the 321st most from all Q2 reports we have seen this year. 22.7% came from individual donors.
Langworthy disclosed $7.9K of spending. This was the 1659th most from all Q2 reports we have seen from politicians so far this year.
Langworthy disclosed $2.5M of cash on hand at the end of the filing period. This was the 186th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Nicholas A. Langworthy's fundraising on Quiver Quantitative.
Nicholas A. Langworthy Net Worth
Quiver Quantitative estimates that Nicholas A. Langworthy is worth $348.0K, as of October 2nd, 2026. This is the 432nd highest net worth in Congress, per our live estimates.
Langworthy has approximately $9.0K invested in publicly traded assets which Quiver is able to track live.
You can track Nicholas A. Langworthy's net worth on Quiver Quantitative's politician page for Langworthy.
Nicholas A. Langworthy Bill Proposals
Here are some bills which have recently been proposed by Nicholas A. Langworthy:
- H.R.10628: To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
- H.R.10571: Surge to Save Newborns Act
- H.R.10522: Companion Animal Protection Against Cruel Testing Act
- H.R.10163: American Quantum Competitiveness Act
- H.R.9806: FLOWS Act
- H.R.9661: Expedited Access to Biosimilars Act
You can track bills proposed by Nicholas A. Langworthy on Quiver Quantitative's politician page for Langworthy.
2026 New York's 23rd Congressional District Election
There has been approximately $12,975,472 of spending in New York's 23rd congressional district elections over the last two years, per our estimates.
The rating for this race is currently "Solid R".
You can track this election on our matchup page for the 2026 New York's 23rd congressional district election.
